{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:08:05Z","timestamp":1787875685467,"version":"build-2784847793"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Although cure rates for early stage anal squamous cell cancer (ASCC) are overall high, there may be racial disparities in receipt of treatment and outcome precluding favorable outcomes across all patient demographics. Therefore, the authors aimed to assess the time to treatment initiation and overall survival (OS) in Black and White patients receiving definitive chemoradiation for early stage ASCC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>The authors identified patients diagnosed with early stage (stage I-II) ASCC and treated with chemoradiation diagnosed between 2004 and 2016 in the National Cancer Database. Clinical and treatment variables were compared by race using the \u03c7<jats:sup>2<\/jats:sup> test, and OS assessed through Cox regression with 1:1 nearest neighbor propensity score matching.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 9331 patients, 90.6% were White. Black patients had longer median time to treatment initiation as compared with White patients (47 vs. 36\u2009d, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and on multivariable analysis, the Black race was associated with higher odds of &gt;6 weeks of time to treatment initiation (hazard ratio, 1.78; 95% confidence interval, 1.53-2.08; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). Furthermore, Black patients had worse OS (5-year survival 71% vs. 77%; <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), which persisted after propensity score matching (<jats:italic toggle=\"yes\">P=<\/jats:italic>0.007).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Black patients had a longer time to treatment initiation and worse OS as compared with White patients with early stage ASCC treated with chemoradiation. Further research is needed to better elucidate the etiologies of these disparities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000744","type":"journal-article","created":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T18:00:44Z","timestamp":1597600844000},"page":"762-769","source":"Crossref","is-referenced-by-count":11,"title":["Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Suleyman Y.","family":"Goksu","sequence":"first","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet","family":"Ozer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Capital Health Regional Medical Center, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M.A.","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Aguilera","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hsiehchen","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind","family":"Sanjeevaiah","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary C.","family":"Maxwell","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad S.","family":"Beg","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina N.","family":"Sanford","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","article-title":"Changing patterns of anal canal carcinoma in the United States","volume":"31","author":"Nelson","year":"2013","journal-title":"J Clin Oncol"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.critrevonc.2018.12.007","article-title":"Cancer of the anal region","volume":"135","author":"Valvo","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jnci\/djs371","article-title":"Impact of the HIV epidemic on the incidence rates of anal cancer in the United States","volume":"104","author":"Shiels","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/ijc.24215","article-title":"Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions","volume":"124","author":"Hoots","year":"2009","journal-title":"Int J Cancer"},{"key":"R7-20230903","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","author":"Alemany","year":"2015","journal-title":"Int J Cancer"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/oxfordjournals.aje.a117073","article-title":"Changing patterns of anal cancer incidence in the United States, 1940-1989","volume":"139","author":"Melbye","year":"1994","journal-title":"Am J Epidemiol"},{"key":"R9-20230903","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3322\/caac.21259","article-title":"Anal cancer: current standards in care and recent changes in practice","volume":"65","author":"Shridhar","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R10-20230903","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MPA.0000000000000323","article-title":"Pancreatic cancer disparities in African Americans","volume":"44","author":"Khawja","year":"2015","journal-title":"Pancreas"},{"key":"R11-20230903","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/tbj.12369","article-title":"Disparities in breast cancer and African ancestry: a global perspective","volume":"21","author":"Newman","year":"2015","journal-title":"Breast J"},{"key":"R12-20230903","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.currproblcancer.2007.02.002","article-title":"Racial disparities in lung cancer","volume":"31","author":"Berger","year":"2007","journal-title":"Curr Probl Cancer"},{"key":"R13-20230903","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2741\/4515","article-title":"Racial disparities in prostate cancer: a molecular perspective","volume":"22","author":"Bhardwaj","year":"2017","journal-title":"Front Biosci (Landmark Ed)"},{"key":"R14-20230903","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/heq.2018.0018","article-title":"Racial disparities and the effect of county level income on the incidence and survival of young men with anal cancer","volume":"2","author":"Bojko","year":"2018","journal-title":"Health Equity"},{"key":"R15-20230903","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jss.2018.05.050","article-title":"The impact of location on the prognosis of squamous cell carcinomas of the anorectal region","volume":"231","author":"Goffredo","year":"2018","journal-title":"J Surg Res"},{"key":"R16-20230903","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1245\/s10434-018-6449-y","article-title":"A national-level validation of the new American Joint committee on cancer 8th edition subclassification of stage IIA and B anal squamous cell cancer","volume":"25","author":"Goffredo","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R17-20230903","doi-asserted-by":"crossref","first-page":"616","DOI":"10.21037\/jgo.2019.02.06","article-title":"Survival benefits and predictors of use of chemoradiation compared with radiation alone for early stage (T1-T2N0) anal squamous cell carcinoma","volume":"10","author":"Youssef","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"R18-20230903","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3816\/CCC.2010.n.035","article-title":"Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer","volume":"9","author":"Hauerstock","year":"2010","journal-title":"Clin Colorectal Cancer"},{"key":"R19-20230903","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.21037\/jgo.2018.08.07","article-title":"Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis","volume":"9","author":"Ramey","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"R20-20230903","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1002\/cncr.31721","article-title":"Intensity\u2010modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: a National Cancer Data Base study","volume":"124","author":"Elson","year":"2018","journal-title":"Cancer"},{"key":"R21-20230903","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/DCR.0b013e31819eb7f0","article-title":"Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base","volume":"52","author":"Bilimoria","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"R22-20230903","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1245\/s10434-008-9905-2","article-title":"Squamous cell carcinoma of the anal canal: utilization and outcomes of recommended treatment in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"R23-20230903","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R24-20230903","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R26-20230903","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1037\/hea0000242","article-title":"Understanding associations among race, socioeconomic status, and health: patterns and prospects","volume":"35","author":"Williams","year":"2016","journal-title":"Health Psychol"},{"key":"R27-20230903","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cardfail.2010.09.016","article-title":"Racial disparities in health literacy and access to care among patients with heart failure","volume":"17","author":"Chaudhry","year":"2011","journal-title":"J Card Fail"},{"key":"R28-20230903","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1186\/s12889-016-3621-9","article-title":"Examining health literacy disparities in the United States: a third look at the National Assessment of Adult Literacy (NAAL)","volume":"16","author":"Rikard","year":"2016","journal-title":"BMC Public Health"},{"key":"R29-20230903","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canep.2016.09.005","article-title":"Treatment delays, race, and outcomes in head and neck cancer","volume":"45","author":"Naghavi","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"R30-20230903","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1245\/s10434-014-4086-7","article-title":"Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base","volume":"22","author":"Liederbach","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R31-20230903","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.3747\/co.19.1073","article-title":"Disparities in timeliness of care for U.S. Medicare patients diagnosed with cancer","volume":"19","author":"Halpern","year":"2012","journal-title":"Curr Oncol"},{"key":"R32-20230903","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/cncr.20169","article-title":"Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma","volume":"100","author":"Gwyn","year":"2004","journal-title":"Cancer"},{"key":"R33-20230903","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00005650-200502000-00007","article-title":"Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment","volume":"43","author":"Elmore","year":"2005","journal-title":"Med Care"},{"key":"R34-20230903","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2000.18.3.584","article-title":"Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group","volume":"18","author":"Colleoni","year":"2000","journal-title":"J Clin Oncol"},{"key":"R35-20230903","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1200\/JCO.2013.54.3942","article-title":"Time to initiation of adjuvant chemotherapy for early breast cancer and outcome: the earlier, the better?","volume":"32","author":"Colleoni","year":"2014","journal-title":"J Clin Oncol"},{"key":"R36-20230903","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/1055-9965.EPI-15-0044","article-title":"Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior","volume":"24","author":"Shiels","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R37-20230903","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"R38-20230903","doi-asserted-by":"crossref","first-page":"998","DOI":"10.6004\/jnccn.2017.0135","article-title":"Race- and sex-based disparities in the therapy and outcomes of squamous cell carcinoma of the anus","volume":"15","author":"Arora","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"R39-20230903","first-page":"968","article-title":"Disparities in receipt of radiotherapy and survival by age, sex, and race among patients with non-metastatic squamous cell carcinoma of the anus","volume":"7","author":"Baughman","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"R40-20230903","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/jso.25712","article-title":"Does race impact survival for patients with anal squamous cell carcinoma?","volume":"120","author":"Fields","year":"2019","journal-title":"J Surg Oncol"},{"key":"R41-20230903","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/DCR.0000000000000555","article-title":"Conditional survival in anal carcinoma using the National Population-Based Survey of Epidemiology and End Results Database (1988-2012)","volume":"59","author":"Kim","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"R42-20230903","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/000313481307901023","article-title":"Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry","volume":"79","author":"Metildi","year":"2013","journal-title":"Am Surg"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:09:32Z","timestamp":1693714172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000744","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}